iBio Inc (IBIO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

iBio Inc (IBIO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH140013D
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It uses its ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, other therapeutic proteins and vaccines. iBio is developing therapeutic product for the treatment of idiopathic pulmonary fibrosis, systemic scleroderma and other fibrotic diseases, and others. The company's IBIO-CFB03 is helpful for the treatment of idiopathic pulmonary fibrosis, fibrotic diseases and systemic sclerosis, among others. It collaborates with medical universities for its research and development activities. iBio is headquartered in New York, the US.

iBio Inc (IBIO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

iBio Inc, Medical Devices Deals, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deal Details

Partnerships

iBio Enters into Agreement with AzarGen Biotechnologies

Texas A&M University Enters into Agreement with iBio

iBio Amends Agreement with Medical University of South Carolina

Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies

iBio Enters into Agreement with Novici Biotech

Licensing Agreements

iBio Amends Licensing Agreement with US University

iBio Enters into Licensing Agreement with University of Pittsburgh

iBio Enters Into Licensing Agreement With Caliber Biotherapeutics

iBio Enters into Licensing Agreement with Caliber Biotherapeutics

iBio Extends Licensing Agreement with Fraunhofer

iBio Extends its Licensing Agreement with Bio-Manguinhos

Equity Offering

iBio Raises USD4.5 Million in Public Offering of Shares

iBio to Raise Funds in Public Offering of Shares

iBio Raises USD1 Million in First Tranche of Private Placement of Shares

iBio Raises USD4 Million in Second and Final Tranche of Private Placement of Shares

iBio Raises USD2.2 Million in First Tranche of Private Placement of Shares

iBio Raises USD1 Million in Private Placement of Shares up on Exercise of Warrants

iBio Raises USD0.9 Million in Private Placement of Shares up on Exercise of Warrants

iBio Plans to Raise up to USD15 Million in Private Placement of Shares

iBio Raises USD10 Million in Private Placemet of Shares

iBio Raises USD0.5 Million in First Tranche of Private Placement of Shares

Ibio Completes Public Offering Of Units For USD4 Million

iBio, Biotechnology Company, Completes Public Offering Of Common Stock For USD10 Million

iBio Inc-Key Competitors

iBio Inc-Key Employees

iBio Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Legal and Regulatory

Nov 06, 2017: iBio Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court

Product News

Mar 07, 2018: iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics

Other Significant Developments

Oct 30, 2017: iBio CDMO President to Co-Chair South African Molecular Pharming Conference

May 04, 2017: iBio Provides Corporate Update at Annual Shareholders Meeting

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Figures

iBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

iBio Inc, Medical Devices Deals, 2012 to YTD 2018

List of Tables

iBio Inc, Pharmaceuticals & Healthcare, Key Facts, 2017

iBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

iBio Inc, Deals By Therapy Area, 2012 to YTD 2018

iBio Inc, Medical Devices Deals, 2012 to YTD 2018

iBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

iBio Enters into Agreement with AzarGen Biotechnologies

Texas A&M University Enters into Agreement with iBio

iBio Amends Agreement with Medical University of South Carolina

Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies

iBio Enters into Agreement with Novici Biotech

iBio Amends Licensing Agreement with US University

iBio Enters into Licensing Agreement with University of Pittsburgh

iBio Enters Into Licensing Agreement With Caliber Biotherapeutics

iBio Enters into Licensing Agreement with Caliber Biotherapeutics

iBio Extends Licensing Agreement with Fraunhofer

iBio Extends its Licensing Agreement with Bio-Manguinhos

iBio Raises USD4.5 Million in Public Offering of Shares

iBio to Raise Funds in Public Offering of Shares

iBio Raises USD1 Million in First Tranche of Private Placement of Shares

iBio Raises USD4 Million in Second and Final Tranche of Private Placement of Shares

iBio Raises USD2.2 Million in First Tranche of Private Placement of Shares

iBio Raises USD1 Million in Private Placement of Shares up on Exercise of Warrants

iBio Raises USD0.9 Million in Private Placement of Shares up on Exercise of Warrants

iBio Plans to Raise up to USD15 Million in Private Placement of Shares

iBio Raises USD10 Million in Private Placemet of Shares

iBio Raises USD0.5 Million in First Tranche of Private Placement of Shares

Ibio Completes Public Offering Of Units For USD4 Million

iBio, Biotechnology Company, Completes Public Offering Of Common Stock For USD10 Million

iBio Inc, Key Competitors

iBio Inc, Key Employees

iBio Inc, Subsidiaries

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 16998
Site License
USD 500 INR 33995
Corporate User License
USD 750 INR 50993

NEWSLETTER BY CATEGORY




Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com